Ieq Capital LLC Purchases 298 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Ieq Capital LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 10.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,149 shares of the biotechnology company’s stock after acquiring an additional 298 shares during the quarter. Ieq Capital LLC’s holdings in Axon Enterprise were worth $1,872,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Asset Dedication LLC increased its stake in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares during the period. Bleakley Financial Group LLC boosted its stake in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after acquiring an additional 20 shares in the last quarter. Venturi Wealth Management LLC grew its stake in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after acquiring an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC grew its holdings in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Down 5.3 %

Shares of NASDAQ:AXON opened at $513.22 on Monday. The firm’s 50-day moving average is $619.94 and its two-hundred day moving average is $519.86. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The firm has a market capitalization of $39.13 billion, a PE ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05.

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock valued at $5,631,561 in the last 90 days. Company insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on AXON. Northland Securities lifted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective for the company. in a research report on Thursday. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.